Published online before print November 21, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Department of Molecular Cell Biology, VU Medical Center, Amsterdam, The Netherlands; and
The Netherlands Cancer Institute, Antoni van Leeuwenhoekziekenhuis, Amsterdam
1 Correspondence: Department of Molecular Cell Biology, VU Medical Center, Postbus 7057, 1007 MB Amsterdam, The Netherlands. E-mail: HE.de_Vries.cell{at}med.vu.nl
Monocyte infiltration into inflamed tissue requires the initial arrest of the cells on the endothelium followed by firm adhesion and their subsequent migration. Migration of monocytes and other leukocytes is believed to involve a coordinated remodeling of the actin cytoskeleton. The small GTPases RhoA, Rac1, and Cdc42 are critical regulators of actin reorganization. In this study, we have investigated the role of Rho-like GTPases RhoA, Rac1, and Cdc42 in the adhesion and migration of monocytes across brain endothelial cells by expressing their constitutively active or dominant-negative constructs in NR8383 rat monocytic cells. Monocytes expressing the active form of Cdc42 show a reduced migration, whereas Rac1 expression did not affect adhesion or migration. In contrast, expression of the active form of RhoA in monocytes leads to a dramatic increase in their adhesion and migration across endothelial cells. The effect of RhoA was found to be mediated by its down-stream effector Rho kinase (ROCK), as pretreatment with the selective ROCK inhibitor Y-27632 prevented this enhanced adhesion and migration. These results demonstrate that RhoA activation in monocytes is sufficient to enhance adhesion and migration across monolayers of endothelial cells.
Key Words: GTPase • brain endothelium • cytoskeleton
This article has been cited by other articles:
 |
|
 |
|
  S. B. Haudek, D. Gupta, O. Dewald, R. J. Schwartz, L. Wei, J. Trial, and M. L. Entman Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation Cardiovasc Res, June 5, 2009; (2009) cvp135v3. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-W. Wang, P.-Y. Liu, N. Oyama, Y. Rikitake, S. Kitamoto, J. Gitlin, J. K. Liao, and W. A. Boisvert Deficiency of ROCK1 in bone marrow-derived cells protects against atherosclerosis in LDLR-/- mice FASEB J, October 1, 2008; 22(10): 3561 - 3570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, T. Syrovets, S. Paskas, Y. Laumonnier, and T. Simmet Mature Dendritic Cells Express Functional Thrombin Receptors Triggering Chemotaxis and CCL18/Pulmonary and Activation-Regulated Chemokine Induction J. Immunol., July 15, 2008; 181(2): 1215 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Schaafsma, I. S. T. Bos, A. B. Zuidhof, J. Zaagsma, and H. Meurs The inhaled Rho kinase inhibitor Y-27632 protects against allergen-induced acute bronchoconstriction, airway hyperresponsiveness, and inflammation Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L214 - L219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chiba, J. Arima, H. Sakai, and M. Misawa Lovastatin inhibits bronchial hyperresponsiveness by reducing RhoA signaling in rat allergic asthma Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L705 - L713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hidaka, Y. Suzuki, M. Yamashita, T. Shibata, Y. Tanaka, S. Horikoshi, and Y. Tomino Amelioration of Crescentic Glomerulonephritis by RhoA Kinase Inhibitor, Fasudil, through Podocyte Protection and Prevention of Leukocyte Migration Am. J. Pathol., March 1, 2008; 172(3): 603 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Fernandes, P. J. Henry, and R. G. Goldie Review: Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 25 - 33. [Abstract] [PDF]
|
|
|
|
|
|
J.-P. Segain, M. Rolli-Derkinderen, N. Gervois, D. Raingeard de la Bletiere, G. Loirand, and P. Pacaud Urotensin II is a New Chemotactic Factor for UT Receptor-Expressing Monocytes J. Immunol., July 15, 2007; 179(2): 901 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kajimoto, K. Hashimoto, S. N. Bonnet, A. Haromy, G. Harry, R. Moudgil, T. Nakanishi, I. Rebeyka, B. Thebaud, E. D. Michelakis, et al. Oxygen Activates the Rho/Rho-Kinase Pathway and Induces RhoB and ROCK-1 Expression in Human and Rabbit Ductus Arteriosus by Increasing Mitochondria-Derived Reactive Oxygen Species: A Newly Recognized Mechanism for Sustaining Ductal Constriction Circulation, April 3, 2007; 115(13): 1777 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Rahat, B. Marom, H. Bitterman, L. Weiss-Cerem, A. Kinarty, and N. Lahat Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association J. Leukoc. Biol., April 1, 2006; 79(4): 706 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Simoes and I. M. Fierro Involvement of the Rho-Kinase/Myosin Light Chain Kinase Pathway on Human Monocyte Chemotaxis Induced by ATL-1, an Aspirin-Triggered Lipoxin A4 Synthetic Analog J. Immunol., August 1, 2005; 175(3): 1843 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Soderstrom, S. D. Nyberg, and J. E. Eriksson CD95 capping is ROCK-dependent and dispensable for apoptosis J. Cell Sci., May 15, 2005; 118(10): 2211 - 2223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J.A. Hendriks, J. Alblas, S. M.A. van der Pol, E. A.F. van Tol, C. D. Dijkstra, and H. E. de Vries Flavonoids Influence Monocytic GTPase Activity and Are Protective in Experimental Allergic Encephalitis J. Exp. Med., December 20, 2004; 200(12): 1667 - 1672. [Abstract] [Full Text] [PDF]
|
|
